Physician

Paul Willian Conrad, MD PHD

According to 2025 Medicare claims, Paul Conrad, MD PHD (NPI: 1205954427) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS INC. (NPI: 1063444123; TIN: 251492985) and primary practice location at 16601-4812.

Conrad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 651 traditional Medicare patients, billed 22,681 HCPCS/CPT codes, and received $1,911,761 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 593 prescription claims across 177 beneficiaries totaling $20,847 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $860,624 to $1,911,761. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $71,214 to $20,847. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$956K$1.9M2015 Medicare payment: $860,624 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,134,544 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,093,103 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,074,977 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,147,548 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,286,804 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,384,138 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,432,680 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,510,278 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,911,761 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154444,425$860,624
20165365,676$1,134,544
20175145,281$1,093,103
20185164,828$1,074,977
20195064,809$1,147,548
20205164,842$1,286,804
20215175,024$1,384,138
20225745,637$1,432,680
20235189,153$1,510,278
202465122,681$1,911,761

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$42K$84K2015 Drug cost: $71,214 (USD; Tot_Drug_Cst)2016 Drug cost: $83,935 (USD; Tot_Drug_Cst)2017 Drug cost: $74,023 (USD; Tot_Drug_Cst)2018 Drug cost: $48,768 (USD; Tot_Drug_Cst)2019 Drug cost: $31,925 (USD; Tot_Drug_Cst)2020 Drug cost: $31,400 (USD; Tot_Drug_Cst)2021 Drug cost: $38,150 (USD; Tot_Drug_Cst)2022 Drug cost: $46,479 (USD; Tot_Drug_Cst)2023 Drug cost: $24,756 (USD; Tot_Drug_Cst)2024 Drug cost: $20,847 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015102304$71,214
2016130402$83,935
2017147476$74,023
2018120406$48,768
2019102332$31,925
2020124403$31,400
2021137471$38,150
2022131505$46,479
2023141455$24,756
2024177593$20,847

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1921,502$656
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more134134$121
67028Injection of drug into eye3661,157$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more421716$67
92134Imaging of retina548992$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1625,898$5,574
LumiganBimatoprost15475$5,194
Brimonidine TartrateBrimonidine Tartrate1075,448$1,508
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat674,864$1,370
Ketorolac TromethamineKetorolac Tromethamine842,519$859

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Paul Willian Conrad, MD PHD?

Tedicare shows public-source Medicare data for Paul Willian Conrad, MD PHD (NPI 1205954427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Willian Conrad, MD PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Willian Conrad, MD PHD?

Paul Willian Conrad, MD PHD is linked to RETINA VITREOUS CONSULTANTS INC. (billing NPI 1063444123) in the available physician profile data.

Does Paul Willian Conrad, MD PHD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.